JP2010536745A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536745A5
JP2010536745A5 JP2010520684A JP2010520684A JP2010536745A5 JP 2010536745 A5 JP2010536745 A5 JP 2010536745A5 JP 2010520684 A JP2010520684 A JP 2010520684A JP 2010520684 A JP2010520684 A JP 2010520684A JP 2010536745 A5 JP2010536745 A5 JP 2010536745A5
Authority
JP
Japan
Prior art keywords
fibronectin
erythropoietin
dose
tissue
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010520684A
Other languages
English (en)
Japanese (ja)
Other versions
JP5869219B2 (ja
JP2010536745A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2008/001119 external-priority patent/WO2009022338A2/en
Publication of JP2010536745A publication Critical patent/JP2010536745A/ja
Publication of JP2010536745A5 publication Critical patent/JP2010536745A5/ja
Application granted granted Critical
Publication of JP5869219B2 publication Critical patent/JP5869219B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010520684A 2007-08-16 2008-08-13 治療および美容適用のためのエリスロポイエチンおよびフィブロネクチン組成物 Active JP5869219B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US93549707P 2007-08-16 2007-08-16
US60/935,497 2007-08-16
US6431108P 2008-02-27 2008-02-27
US61/064,311 2008-02-27
PCT/IL2008/001119 WO2009022338A2 (en) 2007-08-16 2008-08-13 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications

Publications (3)

Publication Number Publication Date
JP2010536745A JP2010536745A (ja) 2010-12-02
JP2010536745A5 true JP2010536745A5 (enExample) 2011-09-29
JP5869219B2 JP5869219B2 (ja) 2016-02-24

Family

ID=40351263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010520684A Active JP5869219B2 (ja) 2007-08-16 2008-08-13 治療および美容適用のためのエリスロポイエチンおよびフィブロネクチン組成物

Country Status (5)

Country Link
US (7) US20110123481A1 (enExample)
EP (1) EP2192907B1 (enExample)
JP (1) JP5869219B2 (enExample)
PL (1) PL2192907T3 (enExample)
WO (1) WO2009022338A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5564735B2 (ja) * 2009-07-31 2014-08-06 国立大学法人 熊本大学 アクアポリン3の発現調節剤
US20120315254A1 (en) * 2010-02-23 2012-12-13 Sebana Medical Ltd. Methods and compositions for enhancing fat graft survival
WO2014160496A1 (en) * 2013-03-13 2014-10-02 Stemetrix, Inc. Skin compositions and uses
KR102240373B1 (ko) * 2013-05-07 2021-04-13 고쿠리츠 다이가쿠호우징 도쿄이카시카다이가쿠 입자상 탈세포화 조직의 제조방법
JP7242298B2 (ja) 2015-09-04 2023-03-20 レメドー バイオメッド リミテッド 局所エリスロポエチン製剤および前記製剤を用いて創傷治癒を改善するための方法および前記製剤の美容用途
WO2017104725A1 (ja) * 2015-12-16 2017-06-22 第一三共株式会社 創傷治療剤
CN109071482A (zh) 2016-01-15 2018-12-21 汉堡大学 携有o-鼠李糖基残基的类黄酮型化合物
US20190203240A1 (en) 2016-01-15 2019-07-04 Universitaet Hamburg Methods for the production of rhamnosylated flavonoids
WO2017223245A1 (en) * 2016-06-21 2017-12-28 The Regents Of The University Of California Wound healing using braf inhibitors
EP3538065B1 (en) * 2016-11-10 2023-08-02 ASC Regenity Ltd. Cosmetic formulations for topical applications containing erythropoietin-derived molecules
JP7605576B2 (ja) * 2018-07-25 2024-12-24 ポーラ化成工業株式会社 皮膚老化改善剤のスクリーニング方法
JP2020070270A (ja) * 2018-11-01 2020-05-07 御木本製薬株式会社 フィブロネクチン遺伝子発現促進剤
CN116531306A (zh) * 2023-02-27 2023-08-04 珠海盈盛联科生物科技有限公司 含重组人纤连蛋白具有修复功效组合物、制备方法及应用

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
DE2437090A1 (de) 1974-08-01 1976-02-19 Hoechst Ag Reinigungsmittel
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US5124155A (en) 1988-06-21 1992-06-23 Chiron Ophthalmics, Inc. Fibronectin wound-healing dressings
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5264214A (en) 1988-11-21 1993-11-23 Collagen Corporation Composition for bone repair
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5073372A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5564345A (en) * 1993-05-11 1996-10-15 Park Ohio Industries Inc. Stackable table, table assembly, and tray and table combination
WO1994013692A1 (en) * 1992-12-10 1994-06-23 Regents Of The University Of Minnesota Polypeptides useful for treating inflammatory disorders
GB9315810D0 (en) * 1993-07-30 1993-09-15 Univ London Stabilised materials
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US6458889B1 (en) * 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6007802A (en) 1996-03-27 1999-12-28 The Procter & Gamble Co. Conditioning shampoo composition
EP0992232A4 (en) * 1997-03-11 2003-01-02 Pola Chem Ind Inc TESTING METHODS OF SKIN CARE AGENTS AND EXTERNAL SKIN CARE PRODUCTS MANUFACTURING METHOD
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
CA2316015A1 (en) * 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6194378B1 (en) * 1998-02-18 2001-02-27 The Research Foundation Of State University Of New York Fibronectin peptides-based extracellular matrix for wound healing
GB9804720D0 (en) 1998-03-05 1998-04-29 Unilever Plc Shampoo compositions
WO2000004941A1 (en) 1998-07-24 2000-02-03 Pharmacal Biotechnologies, Inc. Osseous tissue reconstruction system and method
US20020006418A1 (en) * 1998-10-13 2002-01-17 John Kung Composition to enhance permeation of topical skin agents
US20070129282A1 (en) 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
WO2006120681A2 (en) * 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions and methods for skin care
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US6960173B2 (en) 2001-01-30 2005-11-01 Eilaz Babaev Ultrasound wound treatment method and device using standing waves
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6913762B2 (en) 2001-04-25 2005-07-05 Mayo Foundation For Medical Education And Research Stent having non-woven framework containing cells
US20030147825A1 (en) * 2001-06-08 2003-08-07 Chiarelli Joseph A. Personal care compostions containing inverse emulsion polymers
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US20030068297A1 (en) * 2001-08-18 2003-04-10 Deepak Jain Composition and methods for skin rejuvenation and repair
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7622299B2 (en) 2002-02-22 2009-11-24 University Of Washington Bioengineered tissue substitutes
JPWO2003103703A1 (ja) 2002-06-06 2005-10-06 中外製薬株式会社 骨代謝疾患治療剤
JP5144876B2 (ja) 2002-06-20 2013-02-13 バーダー、アウグスティヌス 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス
DE10234192B4 (de) 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
DE10303584A1 (de) 2003-01-30 2004-08-12 Stauss, Robert, Dr. Verwendung von Erythropoietin (EPO) als ein Beschichtungsmaterial auf medizinischen Implantaten
EP1601757B1 (en) 2003-02-24 2016-11-30 Marine Polymer Technologies, Inc. Cell-polymer fiber compositions and use thereof
US7459152B2 (en) 2003-04-23 2008-12-02 Rush University Medical Center Erythropoietin administration to improve graft survival
EP1673102A1 (en) * 2003-10-17 2006-06-28 Crucell Holland B.V. Treatment and prevention of decubitus
CA2536041A1 (en) 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
EP1550715A1 (de) 2003-12-30 2005-07-06 Bionethos Holding Gmbh Verfahren zur Regenation von Gewebe
BRPI0418326A (pt) 2003-12-30 2007-05-02 Bionethos Holding Gmbh método de regeneração de tecidos
US20050187158A1 (en) * 2004-01-22 2005-08-25 Ranby Mats G. Pharmaceutical composition
DE102004063927A1 (de) * 2004-01-23 2005-12-15 Epoplus Gmbh Co.Kg Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US20060228416A1 (en) * 2005-04-06 2006-10-12 Marie-Pierre Faure Methods for modulating topical inflammatory response
DE102005019712A1 (de) * 2005-04-28 2006-11-09 Bayer Healthcare Ag Dipyridyl-dihydropyrazolone und ihre Verwendung
US7312198B2 (en) * 2005-07-12 2007-12-25 Essential Skincare, Llc Protein compositions for promoting wound healing and skin regeneration
WO2007055760A2 (en) 2005-10-31 2007-05-18 Essential Skincare, Llc Protein composition for promoting wound healing and skin regeneration
WO2007087402A2 (en) 2006-01-24 2007-08-02 Brown University Cell aggregation and encapsulation device and method
EP2656832B1 (en) * 2006-05-11 2018-12-19 Regenics AS Compositions for use in wound healing
AR063621A1 (es) * 2006-11-09 2009-02-04 Alcon Res Ltd Matriz polimerica insoluble en agua para la administracion de farmacos
US7717855B2 (en) * 2006-12-06 2010-05-18 The Hospital For Sick Children System for performing remote ischemic preconditioning
EP2337544A2 (en) * 2007-04-30 2011-06-29 Living Proof, Inc. Use of matrix metalloproteinase inhibitors in skin care
WO2008157733A2 (en) 2007-06-19 2008-12-24 Baxter International Inc. Fibrin gel for controlled release of pdgf and uses thereof
EP2018835B1 (de) * 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
US20090045968A1 (en) 2007-08-16 2009-02-19 Optimal Innovations Inc. Utility Outlets Capable of Presenting Images
EP2222327B1 (de) 2007-12-28 2017-02-15 Augustinus Bader Topische anwendung und formulierung von erythropoietin für die wundheilung der haut
WO2009093240A2 (en) 2008-01-24 2009-07-30 Ademex Ltd. Erythropoietin and fibronectin compositions for bone regeneration

Similar Documents

Publication Publication Date Title
JP2010536745A5 (enExample)
US9839693B2 (en) Anhydrous hydrogel composition and delivery system
ES2720271T3 (es) Composiciones de gel tópico que contienen un polímero de policaprolactona y métodos para mejorar la aplicación tópica de un agente beneficioso
CN100415246C (zh) 二氧化碳外用剂调制用组合物
CN102949709B (zh) 一种治疗糖尿病足的外用凝胶剂及制备和应用
JP5654987B2 (ja) 日光角化症の処置のための局所用組成物
JP6989157B2 (ja) 電気化学ガス状伝達物質生成組成物及びその使用方法ならびにそれを組み込んだ被覆材及び治療システム
US10369118B2 (en) Method of reducing scarring
JP2002536315A5 (enExample)
CA2933375A1 (en) Topical gel compositions including poly(monostearoyl glycerol-co-succinate) polymer and methods for enhancing the topical application of a benefit agent
RU2012133969A (ru) Локальные трансдермальные композиции дексмедетомидина и способы их применения
CA2891075A1 (en) Dermal compositions containing unnatural hygroscopic amino acids
JP2002526407A5 (enExample)
CN105056286B (zh) 液体创可贴及其制备方法
WO2002094256A1 (en) Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
CN103143052A (zh) 医用胶原敷料及其制备方法和用途
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
RU2010138947A (ru) Состав для топического применения, содержащий микросферы адапалена и клиндамицин
JP2013542954A5 (enExample)
RU2159113C1 (ru) Средство, обладающее противовоспалительным, антисептическим и регенераторным действием
EP2663335A1 (en) A composition for the regeneration of atrophic tissues
US10292997B2 (en) Compositions and methods for stimulating wound healing
CN106880765A (zh) 一种外伤动物模型的构建及促进伤口愈合的方法
JP2005500278A (ja) アルカノールアミンを使用する局所治療
CN102327618A (zh) 一种医用促透剂组合物